Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 10, 2018; 90 (15 Supplement) April 22, 2018

Pre-diagnostic Plasma Polyunsaturated Fatty Acids and the Risk of Amyotrophic Lateral Sclerosis (S4.003)

Eilis O’Reilly, Kjetil Bjornevik, Marjorie McCullough, Laurence Kolonel, Loic Le Marchand, JoAnn Manson, Alberto Ascherio
First published April 9, 2018,
Eilis O’Reilly
1School of Public Health, University College Cork Cork Ireland
2Department of Nutrition, Harvard TH Chan School of Public Health Cork Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kjetil Bjornevik
2Department of Nutrition, Harvard TH Chan School of Public Health Cork Ireland
4Department of Global Public Health and Primary Care, University of Bergen Boston MA United States
54The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjorie McCullough
6Epidemiology Research Program, American Cancer Society Atlanta MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Kolonel
7Epidemiology Program, University of Hawaii Cancer Center Honolulu HI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loic Le Marchand
7Epidemiology Program, University of Hawaii Cancer Center Honolulu HI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JoAnn Manson
8Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Ascherio
3Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Pre-diagnostic Plasma Polyunsaturated Fatty Acids and the Risk of Amyotrophic Lateral Sclerosis (S4.003)
Eilis O’Reilly, Kjetil Bjornevik, Marjorie McCullough, Laurence Kolonel, Loic Le Marchand, JoAnn Manson, Alberto Ascherio
Neurology Apr 2018, 90 (15 Supplement) S4.003;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To examine the association between pre-diagnostic plasma polyunsaturated fatty acid levels and amyotrophic lateral sclerosis (ALS) risk.

Background: Potential etiological mechanisms in ALS such as oxidative stress, excitotoxicity, and inflammation are modulated by polyunsaturated fatty acids in brain neural plasma membranes. Individuals with higher dietary intake of n−3 polyunsaturated fatty acids had lower risk of ALS. On the other hand, high dose n−3 intake in an animal model of ALS appeared to accelerate progression.

Design/Methods: We matched 275 individuals who developed ALS while enrolled in five US prospective cohorts to two enrolled controls of the same age, sex and race. Fatty acids, expressed as percentages of total fatty acids, were measured by gas liquid chromatography. Within and between sample coefficients of variation ranged from <1% to 10% across the eleven polyunsaturated fatty acids detected. Gender-specific multivariable-adjusted risk ratios (RR) of ALS incidence or death were estimated by Cox proportional hazards regression and pooled using inverse-variance weighting.

Results: Individuals with higher plasma alpha-linolenic acid had a lower risk of ALS: in age- and matching factor-adjusted analyses, the RR=0.63 (95% CI: [0.41,0.96] p-for-trend=0.018) comparing quartile 4 to quartile 1. Adjustment for BMI, smoking, education attained, plasma urate and other n−3 polyunsaturated fatty acids, did not materially change the findings. Further adjustment for arachidonic acid attenuated findings in women but not men (p-for-trend= 0.002). Individuals with higher plasma arachidonic acid had a higher risk of ALS: in age- and matching factor-adjusted analyses, RR=1.64 (95% CI: [1.06, 2.54] p-for-trend=0.018) comparing quartile 4 to quartile 1. Adjustment for BMI, smoking, education attained, plasma urate, other n−6 and n−3 polyunsaturated fatty acids did not materially change the findings.

Conclusions: Polyunsaturated fatty acid profile may modulate the risk of ALS. Consumption of foods high in alpha-linolenic acid may help prevent or delay the onset of ALS.

Disclosure: Dr. O'Reilly has nothing to disclose. Dr. Bjornevik has nothing to disclose. Dr. McCullough has nothing to disclose. Dr. Kolonel has nothing to disclose. Dr. Le Marchand has nothing to disclose. Dr. Manson has nothing to disclose. Dr. Ascherio has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (2)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise